SCHEMBL4507910

SCHEMBL4507910

Cc1ccc(NC(=O)O)nc1C

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 5/20 0.58
RAB9A P51151 8/20 0.45
NPC1 O15118 6/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPK1 P28482 1/20 0.45
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
SYK P43405 1/20 0.39
KMT2A Q03164 3/20 0.39
HSD17B10 Q99714 1/20 0.39
GBA1 P04062 2/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9753194 0.86 SORT1 (0.53) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL15966082 0.81 ADORA3 (0.50) SORT1RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL20263290 0.80 SORT1 (0.48) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL25346779 0.80 RAB9A (0.62) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL22548707 0.80 RAB9A (0.43) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL17356339 0.78 SORT1 (0.82) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL6469040 0.77 LCK (0.46) SORT1
SCHEMBL12465535 0.76 RAB9A (0.40) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL15903355 0.75 SORT1 (1.00) SORT1RAB9ANPC1ALDH1A1MAPK1
SCHEMBL21640986 0.75 AHR (0.47) SORT1RAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS SORT1 1489/4885RAB9A 3368/4885NPC1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.